These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36478812)

  • 1. Multispectral imaging for MicroChip electrophoresis enables point-of-care newborn hemoglobin variant screening.
    An R; Huang Y; Rocheleau A; Avanaki A; Thota P; Zhang Q; Man Y; Sekyonda Z; Segbefia CI; Dei-Adomakoh Y; Mensah E; Ohene-Frempong K; Odame I; Owusu-Ansah A; Gurkan UA
    Heliyon; 2022 Dec; 8(12):e11778. PubMed ID: 36478812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-Care Diagnostic Test for Beta-Thalassemia.
    An R; Avanaki A; Thota P; Nemade S; Mehta A; Gurkan UA
    Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Microchip-Based Point-Of-Care Device "Gazelle" for Diagnosis of Sickle Cell Disease in India.
    Shrivas S; Patel M; Kumar R; Gwal A; Uikey R; Tiwari SK; Verma AK; Thota P; Das A; Bharti PK; Shanmugam R
    Front Med (Lausanne); 2021; 8():639208. PubMed ID: 34722554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paper-based microchip electrophoresis for point-of-care hemoglobin testing.
    Hasan MN; Fraiwan A; An R; Alapan Y; Ung R; Akkus A; Xu JZ; Rezac AJ; Kocmich NJ; Creary MS; Oginni T; Olanipekun GM; Hassan-Hanga F; Jibir BW; Gambo S; Verma AK; Bharti PK; Riolueang S; Ngimhung T; Suksangpleng T; Thota P; Werner G; Shanmugam R; Das A; Viprakasit V; Piccone CM; Little JA; Obaro SK; Gurkan UA
    Analyst; 2020 Apr; 145(7):2525-2542. PubMed ID: 32123889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care microchip electrophoresis for integrated anemia and hemoglobin variant testing.
    An R; Man Y; Iram S; Kucukal E; Hasan MN; Huang Y; Goreke U; Bode A; Hill A; Cheng K; Sekyonda Z; Ahuja SP; Little JA; Hinczewski M; Gurkan UA
    Lab Chip; 2021 Oct; 21(20):3863-3875. PubMed ID: 34585199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
    McGann PT; Schaefer BA; Paniagua M; Howard TA; Ware RE
    Am J Hematol; 2016 Feb; 91(2):205-10. PubMed ID: 26537622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory.
    Joutovsky A; Hadzi-Nesic J; Nardi MA
    Clin Chem; 2004 Oct; 50(10):1736-47. PubMed ID: 15388656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin C and hemoglobin O-Arab variants can be diagnosed using the Bio-Rad Variant II high-performance liquid chromatography system without further confirmatory tests.
    Joutovsky A; Nardi M
    Arch Pathol Lab Med; 2004 Apr; 128(4):435-9. PubMed ID: 15043463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies.
    Greene DN; Pyle AL; Chang JS; Hoke C; Lorey T
    Clin Chim Acta; 2012 Aug; 413(15-16):1232-8. PubMed ID: 22515960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for hemoglobin disorders.
    Hoppe CC
    Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
    Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
    J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of haemoglobin phenotypes in newborn infants at the national hospital abuja using high performance liquid chromatography.
    Mohammed-Nafi'u R; Audu LI; Ibrahim M; Wakama TT; Okon EJ
    Niger Postgrad Med J; 2020; 27(3):190-195. PubMed ID: 32687118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of Dry Blood Spots from Newborns by Two High Performance Liquid Chromatography (HPLC) Systems: A Comparison of Their Ability to Diagnose Both Sickle and Non-sickle Hemoglobinopathies.
    Ramani Daruwalla M; Das Gupta A; Pawar R
    Indian J Hematol Blood Transfus; 2021 Jul; 37(3):430-435. PubMed ID: 34267462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High birth prevalence of sickle cell disease in Northwestern Tanzania.
    Ambrose EE; Makani J; Chami N; Masoza T; Kabyemera R; Peck RN; Kamugisha E; Manjurano A; Kayange N; Smart LR
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe".
    Rolla R; Castagno M; Zaffaroni M; Grigollo B; Colombo S; Piccotti S; Dellora C; Bona G; Bellomo G
    Clin Lab; 2014; 60(12):2089-93. PubMed ID: 25651745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA; Makalo L; Sallah A; Saine H; Joof S; Conteh A; Bah R; Camara Jammeh AF; Bass M; Jallow M; Nnodu OE
    Hemoglobin; 2024 Jul; ():1-6. PubMed ID: 38980121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease.
    Nwegbu MM; Isa HA; Nwankwo BB; Okeke CC; Edet-Offong UJ; Akinola NO; Adekile AD; Aneke JC; Okocha EC; Ulasi T; Abjah U; Ugwu NI; Okolo AA; Madu A; Emodi I; Girei A; Balogun TM; Diaku-Akinwumi IN; Ohiaeri C; Brown BJ; Olaniyi JA; Hassan A; Awwalu S; Okoh DA; Nnodu OE
    Hemoglobin; 2017 Mar; 41(2):77-82. PubMed ID: 28617057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.